Company news
BeyondSpring, Inc. news in 2022
BeyondSpring, Inc.'s news releases, calls and decks from 2022, newest first.
BeyondSpring Presents Positive Data with Plinabulin for the Prevention of Docetaxel-Induced Neutropenia in Patients with Non-Small Cell Lung Cancer and Breast Cancer at Three Medical Conferences
December 12, 2022
BeyondSpring Presents New Clinical Evidence of Plinabulin Protection of Granulocyte-Monocyte Progenitor Stem Cells for the Prevention of Chemotherapy-Induced Neutropenia at the ESMO Congress 2022
September 12, 2022
BeyondSpring Announces Three Poster Presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting
April 27, 2022
BeyondSpring Files 2021 Annual Report on Form 20-F
April 13, 2022
BeyondSpring Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update
April 13, 2022
BeyondSpring Announces Organizational Streamlining
January 10, 2022
Calls in 2022
Decks in 2022
- Investor Presentation (October 2022)
Investor deck · 27 slides · October 2022
- Investor Presentation (April 2022)
Investor deck · 45 slides · April 2022